May 2005
Volume 46, Issue 13
ARVO Annual Meeting Abstract  |   May 2005
Exclusion of Nine Positional Candidate Genes for Schnyder Crystalline Corneal Dystrophy
Author Affiliations & Notes
  • A.J. Aldave
    The Jules Stein Eye Institute, Los Angeles, CA
  • S.A. Rayner
    The Jules Stein Eye Institute, Los Angeles, CA
  • J.A. Affeldt
    Department of Ophthalmology, Doheny Eye Institute/ LA County+USC Medical Center, Los Angeles, CA
  • D. Katsev
    Santa Barbara Medical Foundation, Santa Barbara, CA
  • V.S. Yellore
    The Jules Stein Eye Institute, Los Angeles, CA
  • Footnotes
    Commercial Relationships  A.J. Aldave, None; S.A. Rayner, None; J.A. Affeldt, None; D. Katsev, None; V.S. Yellore, None.
  • Footnotes
    Support  The Emily Plumb Estate and Trust
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 4923. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A.J. Aldave, S.A. Rayner, J.A. Affeldt, D. Katsev, V.S. Yellore; Exclusion of Nine Positional Candidate Genes for Schnyder Crystalline Corneal Dystrophy . Invest. Ophthalmol. Vis. Sci. 2005;46(13):4923.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To identify the genetic basis of Schnyder crystalline corneal dystrophy (SCCD) through screening of nine of the thirty–one positional candidate genes in affected patients. Methods: Mutation screening of nine genes (CORT, ENO1, CLSTN1, DFFA, H6PD, KIF1B, PGD, PEX14, and SSB1) that lie within the candidate gene region for SCCD was performed in members of two families affected with SCCD. Results: No presumed pathogenic coding region mutations were identified in affected members in the two families. Sixteen previously described single nucleotide polymorphisms (SNPs), twelve resulting in synonymous substitutions, were identified in seven of the candidate genes in these affected patients. Four previously described SNPs resulting in non–pathogenic missense substitutions were identified: Tyr1087Cys in the KIF1B gene and Asp246Asn in the PGD gene (both identified in the proband of family 2, but not in the proband’s affected daughter); and Pro554Leu and Arg453Gln (identified in an unaffected control) in the H6PD gene. A novel SNP was identified in the H6PD gene, c.754A>C (Asp151Ala) in the proband of family 1, but not in the proband’s affected mother. Conclusions: The exclusion of these nine genes significantly decreases the number of remaining positional candidate genes for SCCD. As the candidate gene region in each SCCD family previously examined with haplotype analysis has been mapped to the same region of chromosome 1, exclusion of these nine positional candidate genes in the families we examined suggests that other genetic factors are involved in SCCD in these and other affected families.

Keywords: degenerations/dystrophies • cornea: stroma and keratocytes • gene screening 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.